「Interleukin‑33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis」の関連論文
-
腎同所性移植モデルを応用した腎がん悪性形質制御機構の解析
-
CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF‐β signaling
-
上部消化管癌に対する第三世代がん治療用ヘルペスウイルス(G47Δ)の治療効果の検討
-
Newly emerged immunogenic neoantigens in established tumors enable hosts to regain immunosurveillance in a T cell-dependent manner
-
マウス扁平上皮癌顎骨浸潤モデルにおける Interleukin-12 発現型第三世代がん治療用 HSV-1 投与効果の検討
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer
-
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
-
The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma
-
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer
-
Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells
-
婦人科悪性腫瘍担癌患者におけるインターロイキン17産生性T細胞の変動と抗腫瘍薬がPD-L1を含む免疫関連因子に与える影響、及びPD-L1とインターロイキン17産生誘導因子との関連性についての検討
-
Low level of stromal lectin-like oxidized LDL receptor 1 and CD8+ cytotoxic T lymphocytes indicate poor prognosis of colorectal cancer
-
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
-
乳腺腫瘍増殖におけるテネイシンCの役割
-
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
-
可溶性ALK1発現型HSV-1のヒト腎細胞癌における治療効果の検討
-
非小細胞肺癌におけるB7-1およびPD-1/PD-L1免疫チェックポイント分子の発現と転移巣での変化
-
扁平上皮癌骨浸潤に関わる分子群の網羅的研究 : インターロイキン 7 の骨吸収への関与
-
皮膚T細胞リンパ腫におけるCD147, Cyclophilin Aの役割
-
Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
-
Elucidation of the factors regulating high invasiveness of pancreatic cancer and the profound involvement of Interleukin 32 in the invasive mechanisms of the tumor cells
-
Understanding the functional role of selected bioactive compounds and altered genes on gastric carcinogenesis of the differentiated subtype using A4gnt-deficient mice model
-
癌性腹膜炎を伴う進行卵巣癌に対する新規治療戦略
-
Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer
-
皮膚発癌と皮膚炎におけるリンパ浮腫の影響
-
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
-
初発・再発膠芽腫組織を使用した腫瘍微小環境の変化の解析とテモゾロミド耐性TS細胞に対する抗PD-L1抗体+M2マクロファージ阻害剤併用療法の検討
-
膵癌における腫瘍浸潤リンパ球と患者の生存に関連した三次リンパ組織の統合分析
-
尿路上皮癌における免疫微小環境の意義
-
がん治療用ウイルスG47Δを用いた肝細胞癌・膵癌の新治療法の開発
-
The roles of adipose-tissue and malignant ascites in the development of peritoneal metastasis and the progression of ovarian cancer
-
がん治療用ウイルスの胆道癌治療への応用と新規機能付加型HSV-1の開発
-
Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer
-
Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours
-
Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma
-
Characterization of mast cells in tumor microenvironment
-
PDGFRα knockout mice promote tumor growth and metastasis via vascular hypoplasia and PDGF-stimulated EGFR activation in LLC (Lewis Lung Carcinoma) subcutaneous transplantation model
-
肺がんの進展における免疫抑制性受容体LILRB4の役割についての検討
-
NK細胞のエフェクター機能制御をターゲットとした複合がん免疫薬物療法に関する研究
-
抗腫瘍エフェクター細胞の誘導におけるNK2Rの役割に関する研究
-
Newly established patient-derived organoid model of intracranial meningioma
-
Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator
-
Evaluation of recombinant vaccinia viruses for oncolytic virotherapy
-
Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production
-
顆粒球系骨髄由来免疫抑制細胞と子宮内膜症進展の関係
-
HER2 標的抗体薬物複合体、トラスツズマブデルクステカン(T-DXd)の免疫系への作用に関する解析
-
肝がんにおけるDGKα阻害による抗腫瘍効果の機序解明に関する研究
-
Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis
-
A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis
-
Role of PD-L1 expression during the progression of submucosal gastric cancer